搜索结果31-40 的 26020 / Relapse
The purpose of this study is to evaluate the magnitude of financial toxicity in newly diagnosed and relapsed multiple myeloma (MM) and amyloidosis (AL) patients ...
... relapse will improve disease-free survival (DFS). Risk stratification will ... relapsed and frontline CD123-positive AML, and antileukemia activity of ...
Daly EJ, et al. Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: A ...
The primary purpose of this study is to assess the safety and effectiveness of ALLO-501A to treat patients with relapsed/refractory large B cell lymphoma (LBCL) ...
Patients at high risk of relapse are eligible for InPACT-pelvis, where they are randomised to either: P. prophylactic PLND Q. no prophylactic PLND. Study of ...
A Study to Evaluate APG2575 Combined with Novel Therapeutic Regimens To Treat Subjects with Relapsed or Refractory Multiple Myeloma and Immunoglobulin Light ...
Filippini G. Ocrelizumab appears to reduce relapse and disability in multiple sclerosis but quality of evidence is moderate. Evidence Based Medicine. 2017 ...
... relapse (Phase I), and to determine the antitumor effectiveness of the ... relapse as measured by the 6-month Progression Free Survival (PFS) rate (Phase II) ...
妙佑医疗国际不为任何公司或产品背书。广告收入为我们的非营利使命提供支持。
浏览妙佑医疗国际出版社提供的畅销书以及书籍和简报的特别优惠。
您的捐赠可以抵税。请您慷慨解囊，和我们一起进行尖端研究和医护，共同推动医学的改变。